INTENSIVE MONITROING OF SINOVAC VACCINE FOR SAFETY AND EFFICACY AMONG INDONESIAN POPULATION

VALERIE KEZIA; DIANA LAILA RAMATILLAH

doi:10.22159/ijap.2022.v14s2.44748

Authors

VALERIE KEZIA Faculty Pharmacy, Universitas 17 Agustus 1945 Jakarta, Jl. Sunter Permai Raya, Jakarta 14350, Indonesia
DIANA LAILA RAMATILLAH Faculty Pharmacy, Universitas 17 Agustus 1945 Jakarta, Jl. Sunter Permai Raya, Jakarta 14350, Indonesia

DOI:

https://doi.org/10.22159/ijap.2022.v14s2.44748

Keywords:

Efficacy and safety, Sinovac-corona vac vaccine, Monitoring

Abstract

Objective: To Evaluate intensively patients taking Sinovac-CoronaVac vaccine for the side effects and effectiveness in preventing COVID infection.

Methods: This is a prospective crossectional study using convenience sampling for all Indonesian populations who received full dose of Sinovac-CoronaVac vaccine.

Results: The efficacy and safety of the Sinovac-CoronaVac vaccine is 96.8%. factors that influence efficacy and safety are side effects with Age, BMI and Gender with p-value<0.05.

Conclusion: There is correlation between side effects of Sinovac-CoronaVac with Age, BMI and Gender for safety and efficacy.

Downloads

Download data is not yet available.

References

Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti MSR, Singh G, Nainggolan L, Nelwan EJ, Khie L, Widhani A, Wijaya E, Wicaksana BMM, Annisa F, Jasirwan OM. Coronavirus disease 2019: tinjauan literatur terkini coronavirus disease 2019. Rev Curr Lit. 2020;7(1):45–67.

Peta Sebaran COVID-19 | Covid19.go.id. Available from: https://covid19.go.id/peta-sebaran-covid19. [Last accessed on 12 Oct 2021]

Coronavirus. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1. [Last accessed on 29 Oct 2021]

Ramatillah DL, Gan SH, Sulaiman SAS, Puja D, Abubakar U, Jaber AAS, Lukas S, Jusnita N. Evaluation of treatment outcome for pneumonia among pre-vaccinated COVID-19 Patients with/without comorbidity in a Public Hospital in Bengkulu, Indonesia. Vaccines. 2021;9(12):1411. doi: 10.3390/vaccines9121411, PMID 34960157.

Ramatillah DL, Isnaini S. Treatment profiles and clinical outcomes of COVID-19 patients at a private hospital in Jakarta. PLOS ONE. 2021;16(4):e0250147. doi: 10.1371/journal.pone.0250147. PMID 33861777.

Halim M. COVID-19 vaccination efficacy and safety literature review. J Immunol allergy. 2021 Feb 2.

Tanriover MD, Doganay HL, Akova M, Guner HR, Azap A, Akhan S, Kose S, Erdinç FS, Akalın EH, Tabak OF, Pullukcu H, Batum O, Simsek Yavuz S, Turhan O, Yıldırmak MT, Koksal I, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Celik I, Bayındır Y, Karaoglan I, Yılmaz A, Ozkul A, Gur H, Unal S, CoronaVac Study Group. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in turkey. Lancet. 2021;398(10296):213-22. doi: 10.1016/S0140-6736(21)01429-X, PMID 34246358.

WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations. Available from: https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations. [Last accessed on 12 Oct 2021]

Indonesia study shows China’s Sinovac vaccine is highly effective-Nikkei Asia. Available from: https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/Indonesia-study-shows-China-s-Sinovac-vaccine-highly-effective. [Last accessed on 14 Oct 2021]

Herd immunity and COVID-19 (coronavirus): What you need to know-mayo clinic. Available from: https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/herd-immunity-and-coronavirus/art-20486808. [Last accessed on 01 Nov 2021]

Kabir R, Mahmud I, Tawfique Hossain Chowdhury M, Vinnakota D, Saif Jahan S, Siddika N. COVID-19 vaccination intent and willingness to pay in Bangladesh: A cross-sectional study CAPABLE-A cambridge-led programme in. 2021; Available from: https://doi.org/10.3390/vaccines9050416.

Elnaem MH, Mohd Taufek NH, Ab Rahman NS, Mohd Nazar NI, Zin CS, Nuffer W, Turner CJ. COVID-19 vaccination attitudes, perceptions, and side effect experiences in Malaysia: do age, gender, and vaccine type matter? Vaccines (Basel). 2021;9(10). doi: 10.3390/vaccines9101156, PMID 34696264.

Savoia E, Piltch Loeb R, Goldberg B, Miller Idriss C, Hughes B, Montrond A, Kayyem J, Testa MA. Predictors of COVID-19 vaccine hesitancy: socio-demographics, co-morbidity, and past experience of racial discrimination. Vaccines (Basel). 2021;9(7). doi: 10.3390/vaccines9070767, PMID 34358184.

Riad A, Sa D, Gıro Glu, Ustün B, Pokorna A, Klugarova J. Clinical medicine prevalence and risk factors of coronavac side effects: an independent cross-sectional study among healthcare workers in turkey. Kemal Kampus Caddesi. 2021;10(1).

Fathur Rachman F, Pramana S. Analysis of Indonesian People’s sentiments about the side effects of the COVID-19 vaccine on twitter. Open Access J Data Sci Appl. 2021;4(1):1-10.

Cox LS, Bellantuono I, Lord JM, Sapey E, Mannick JB, Partridge L. Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults. Lancet Heal Longev. 2020;1(2):e55-7. Available from: http://dx, doi: 10.1016/S2666-7568(20)30011-8.

Biotech S. Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results. 2021;1:1-2.

Products H. Menstrual Changes After Covid 19; 2021:1-2.

Alghamdi A, Ibrahim A, Almutairi R, Joseph M, Alghamdi G, Alhamza A. A cross-sectional survey of side effects after COVID-19 vaccination in Saudi Arabia: male versus female outcomes. J Adv Pharm Educ Res. 2021;11(2):51-6. doi: 10.51847/bCwca2qGfP.

Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, Vom Steeg L, Deshpande S, Narasimhan H, Klein SL. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4:29. doi: 10.1038/s41541-019-0124-6, PMID 31312529.

Dars S, Sayed K, Yousufzai Z. Relationship of menstrual irregularities to BMI and nutritional status in adolescent girls. Pak J Med Sci. 2014;30(1):141-4. doi: 10.12669/ pjms.301.3949, PMID 24639848.